The Hurdles A Clinical Research Tech Vendor Needs To Jump Through To Land Sponsor Contracts

Because of the booming clinical research industry being so attractive for potential technological disruptions, it is with no surprise that new tech startup entrants are attempting to carve out a piece of the market share. The only problem with this is, clinical research decision makers are used to traditional legacy vendors and may take a longer than expected time for startups to garner the requisite trust that clinical trials demands from its vendors.